Investor Webcast: Wednesday, November 26th at 4:00pm ET / 1:00pm PT.Register/View Here: https://us02web.zoom.us/webinar/register/8617635107958/WN_Ka6aNlTZTLuCJPaetQoLuQ.Please join/register at least 5 minutes prior to the call.Questions emailed to info@mustgrow.ca will be addressed during the Q&A portion of the webcast.Saskatoon, Saskatchewan--(Newsfile Corp. - November 25, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biologica ...

Core Insights - The article discusses a significant open-market purchase by John Mitchell Raines, a member of the Board of Directors at FMC Corporation, which more than doubled his direct stake in the company, indicating a belief in potential stock appreciation [3][5]. Company Performance - FMC Corporation's stock has experienced a sharp decline, with shares closing at $13.64 on November 13, 2025, down 74.1% over the previous year [2][6]. - The company reported a 49% year-over-year revenue drop in Q3, totaling $542 million, primarily due to the sale of its business in India [6][7]. - Excluding the impact of the sale, revenue still decreased by 4% year-over-year due to competitive pricing pressures [7]. - The company faced a significant net loss of $569 million in Q3 2025, compared to a net income of $66 million in Q3 2024 [7]. - Free cash flow (FCF) turned negative, dropping from $132 million in Q3 2024 to negative $233 million in 2025, leading to a cut in dividend payments [7]. Insider Transactions - Following the recent transaction, Mr. Raines now holds 0.0110% of FMC Corporation's outstanding shares, increasing his direct ownership from 6,784 to 13,784 shares, a 103.18% increase [2][3]. - The acquisition was valued at over $96,000, reflecting a significant commitment to the company [4].

Market Performance - U.S. stock markets showed resilience despite the first government shutdown in nearly seven years, with major indexes recovering from early declines [1][2] - The Dow Jones Industrial Average rose 0.1% to close at a record high for the second consecutive day, while the S&P 500 increased by 0.3%, also setting a new closing high [2] - The Nasdaq Composite outperformed with a 0.4% rise, nearing its intraday and closing records, and has seen a significant increase of 11.2% in Q3 [2][10] Economic Data and Federal Reserve Outlook - The ADP Employment Report indicated a surprising decline of 32,000 private-sector jobs, the largest monthly drop since March 2023, raising concerns about the labor market [4][5] - U.S. Treasury yields fell following the weak jobs report, with the 10-year yield at 4.106% and the 2-year yield at 3.547%, as investors anticipate a potential Fed rate cut by December [4] - The government shutdown may delay the release of key economic data, complicating the Federal Reserve's decision-making regarding interest rates [5] Upcoming Economic Events - Important economic data releases are scheduled for October, including U.S. International Trade in Goods and Services on October 7 and the advance estimate for GDP on October 30 [6] - A key inflation report (CPI) is set for October 15, followed by the monthly retail sales report on October 16, both critical for the Fed's monetary policy decisions [7] Major Corporate Announcements - Nike, Inc. reported a 1% increase in revenue, surpassing expectations with adjusted earnings per share of $0.49, significantly above the anticipated $0.26 [9][13] - Meta Platforms experienced a nearly 3% decline, continuing a downward trend since its August high, following news of a $14 billion AI infrastructure deal and plans for in-house chip development [13] - Corteva announced plans to separate into two independent companies focused on Crop Protection and Seed, expected to be completed in the second half of 2026 [13] - Rocket Companies completed a $14.2 billion acquisition of Mr. Cooper Group, aiming to enhance homeownership services [13] - Lithium Americas shares surged after the U.S. Department of Energy acquired a 5% stake in the company [13]

Company Overview - CF Industries Holdings, Inc. is based in Northbrook, Illinois, and specializes in manufacturing and selling hydrogen and nitrogen products for various applications including energy, fertilizer, and emissions abatement, with a market cap of $13.8 billion [1] Market Position - CF Industries is classified as a large-cap stock, with its market cap exceeding $10 billion, highlighting its size and influence in the agricultural inputs industry [2] - The company benefits from scale, integration, and cost leadership in nitrogen fertilizer production, supported by efficient manufacturing and access to natural gas [2] - CF's strategic geographic footprint and commitment to operational excellence and sustainability enhance its competitive advantage, allowing for efficient distribution and responsiveness to demand fluctuations [2] Stock Performance - CF's stock has declined 18% from its 52-week high of $104.45, reached on June 16, and has underperformed the S&P 500 Index, which gained 12.2% over the same three-month period [3][4] - Year-to-date, CF shares have risen marginally and increased 4.9% over the past 52 weeks, underperforming the S&P 500's year-to-date gains of 13.8% and 17.4% returns [4] Recent Financial Results - In Q2, CF reported an EPS of $2.37, exceeding Wall Street expectations of $2.35, and revenue of $1.9 billion, surpassing forecasts of $1.7 billion [5] - Despite these results, CF's stock closed down more than 3% following the earnings report [5] Competitive Landscape - The Mosaic Company has outperformed CF, showing a 36% increase year-to-date and 30.8% returns over the past 52 weeks [5] Analyst Sentiment - Wall Street analysts maintain a cautious outlook on CF, with a consensus "Hold" rating from 17 analysts and a mean price target of $93.33, indicating a potential upside of 9% from current levels [6]

Core Viewpoint - The Middlefield Canadian Income Trust reported its half-yearly financial results for the period ending June 30, 2025, highlighting strong performance in dividend-paying Canadian equities amidst geopolitical and economic uncertainties [2][12][13]. Financial Highlights - Dividends paid were 1.375 pence per share quarterly, with a guidance of 5.5 pence per share for 2025, resulting in a yield of 4.3% [6]. - The share price was 129.00 pence, while the net asset value (NAV) per share was 134.61 pence, with net assets totaling £143.3 million [6][68]. Investment Performance - The Fund generated total returns of 13.9% on its share price and 2.6% on net assets, outperforming the benchmark total return of 4.3% [13][48]. - Positive contributions to performance came from stock selection in financials, energy, and real estate sectors, while the utilities sector detracted from performance [13][48]. Sector Exposure - The Fund focuses on larger capitalization Canadian and U.S. high yield equities, particularly in sectors like real estate, financials, and energy [7][9]. - As of June 30, 2025, sector allocations included 23.8% in real estate, 21.4% in energy, and 21.3% in financials, with significant overweights compared to the benchmark [23]. Shareholder Engagement and Strategic Transition - The Fund is pursuing a rollover into a newly created actively managed UCITS ETF, providing shareholders options for cash exit or ETF shares [21][30]. - Engagement with shareholders, particularly Saba Capital Management, has been ongoing to ensure alignment with shareholder interests [19][20]. Gearing and Financial Management - Gearing relative to total assets was consistent at 16%, with net gearing decreasing from 19.3% to 18.4% by June 30, 2025 [22]. - The Fund has no borrowings as of June 30, 2025, following the repayment of existing loans [25][31]. Earnings and Dividends - The Fund's earnings per share totaled 2.82 pence for the six months ended June 30, 2025, with a dividend coverage ratio of 1.03 [26]. - The Board approved a 0.2 pence increase to the annual dividend target, reflecting a commitment to consistent dividend growth [26]. Market Outlook - The Canadian market remains attractive due to economic resilience, sound fiscal management, and favorable political conditions, with Canadian equities trading at a discount to U.S. peers [43][44]. - The Fund is well-positioned to capitalize on trends in financials, real estate, and energy sectors, which are supported by durable cash flows and long-term growth opportunities [43][44].

Financial Performance - Q2 2025 - Net sales increased by 6% to $6.456 billion compared to $6.112 billion in 2Q 2024[35] - Operating EBITDA increased by 13% to $2.164 billion with an Operating EBITDA margin of 33.5%, a 215 bps increase[35] - Operating EPS increased by 20% to $2.20[35] Financial Performance - 1H 2025 - Net sales increased by 3% to $10.873 billion compared to $10.604 billion in 1H 2024[20, 94] - Operating EBITDA increased by 14% to $3.353 billion with an Operating EBITDA margin of 30.8%, a 301 bps increase[20, 92] Segment Performance - Seed - Seed net sales for 2Q 2025 increased by 5% to $4.537 billion[38] - Seed Operating EBITDA margin for 2Q 2025 was 41.1%, an increase of 186 bps[38] - Seed net sales for 1H 2025 increased by 2% to $7.244 billion[50] - Seed Operating EBITDA margin for 1H 2025 was 37.3%, an increase of 280 bps[50] Segment Performance - Crop Protection - Crop Protection net sales for 2Q 2025 increased by 8% to $1.919 billion[60] - Crop Protection Operating EBITDA margin for 2Q 2025 was 17.4%, an increase of 309 bps[60] - Crop Protection net sales for 1H 2025 increased by 3% to $3.629 billion[69] - Crop Protection Operating EBITDA margin for 1H 2025 was 19.6%, an increase of 355 bps[69] FY 2025 Guidance - Revised Operating EBITDA guidance to $3.75 - $3.85 billion, a 13% increase at the mid-point[27] - Expecting ~150 bps improvement in Operating EBITDA margin[12, 27] - Operating EPS guidance revised to $3.00 - $3.20, a 21% increase at the mid-point[27] - Free Cash Flow Conversion expected to be ~50%[27]

Core Viewpoint - MustGrow Biologics Corp. has signed a distribution agreement with Phospholutions Inc. to sell the RhizoSorb® phosphorous efficiency product in Canada, aiming to enhance nutrient use efficiency and support sustainable agriculture [2][5][6]. Group 1: Product Overview - RhizoSorb® is designed to replace conventional fertilizers like monoammonium phosphate (MAP) and diammonium phosphate (DAP) by improving nutrient use efficiency [4][9]. - The product allows farmers to apply up to 50% less phosphorus while maintaining or improving crop yields, potentially saving up to US$20 per acre [5][8]. - RhizoSorb® features a 38% lower salt index, promoting healthier soils and long-term productivity [8]. Group 2: Environmental Impact - The use of RhizoSorb® can reduce CO₂e emissions by 45.2%, phosphorus runoff by 78%, and leaching by 84% compared to conventional MAP fertilizer [6][8]. - The product's efficiency in nutrient release contributes to sustainable farming practices, which are critical for meeting global food demands [7][8]. Group 3: Market Context - Canada has approximately 94.5 million acres of crop production that depend on phosphate, making it a significant market for RhizoSorb® [6]. - The partnership between MustGrow and Phospholutions aligns with their shared mission to improve the global food system through sustainable production solutions [6][9].

Financial Data and Key Metrics Changes - Total revenues for the quarter were $60.6 million, down from $84 million in the same period last year, primarily due to the absence of a $16 million accrual from Syngenta's initial down payment [9][10] - Gross profit for the quarter totaled approximately $24 million, compared to $42.6 million last year, with a gross margin decline from 51% to 39% attributed to the previous year's Syngenta accrual [13][14] - Adjusted EBITDA was $9 million, down from $21.1 million last year, reflecting the impact of the Syngenta down payment accrual [16] Business Line Data and Key Metrics Changes - Crop Protection revenues decreased due to lower sales of non-core products in Argentina, partially offset by higher sales of bioprotection solutions [13] - Integrated Products revenues increased by 26%, driven by accelerated sales of HB4 grain from existing inventory [13] - Crop attrition was influenced by the Syngenta payment effect, but underlying operational inoculant sales were up, slightly offset by Argentine seasonality effects on fertilizers [13] Market Data and Key Metrics Changes - The Argentine market showed reduced commercial activity, with purchasing behavior becoming more aligned with the agronomic calendar rather than speculative patterns [10] - The U.S. and Mexico markets exhibited good growth, indicating early signs of recovery, while Brazil remained in a low season with positive sentiment due to improved soybean prices [11][12] - Overall, the performance in Argentina was not indicative of market status, with expectations for better conditions in the upcoming summer crop season [11] Company Strategy and Development Direction - The company is transitioning to a more sustainable agricultural model, focusing on cash flow performance and working capital management [6][20] - The approval of Rhinotech is expected to enhance the company's product offerings in pest control and plant health, targeting both cash and row crops [6][27] - The company aims to improve profitability through a better product mix and is focusing on scaling its biological solutions across key markets [34] Management's Comments on Operating Environment and Future Outlook - Management noted that the agricultural industry is stabilizing after a rough couple of years, with signs of normalization in some markets [9][10] - The sentiment in Argentina is slowly improving, with expectations for a healthy winter crop season, although recovery from a challenging year is still uncertain [48][50] - The company is optimistic about the future, particularly with the introduction of Rhinotech and the ongoing recovery in key markets [34][56] Other Important Information - The company achieved a $40.7 million improvement in cash from operating activities compared to the previous year, with a focus on working capital efficiency [18][19] - Total debt decreased by $13 million, reflecting improved cash management and working capital strategies [21] Q&A Session Summary Question: Inquiry about cash advancement and working capital unwind - Management indicated an expectation of an additional $10 million from the transition to a lighter model with HB4, aiming for a net working capital of four to four and a half months of sales [40][42] Question: Sentiment in Argentina and macroeconomic conditions - Management noted that sentiment is stabilizing, with expectations for a healthy winter crop season and no increase in export tax duties [48][49] Question: Impact of credit conditions in Brazil on customer purchasing - Management confirmed that they have not been affected by tightening credit conditions in Brazil, with positive sentiment due to soybean pricing [72][76] Question: Field trial results for Neovil product - Management stated that ongoing replicated third-party field trials are underway, with positive feedback from partners regarding the product's performance [86][88] Question: Interest in HB4 soybean and wheat traits from seed companies - Management confirmed ongoing collaboration with public and private institutions for HB4 wheat in the U.S., with a focus on Latin America for HB4 soybean [91][92]

Financial Data and Key Metrics Changes - Corteva reported a 15% year-over-year increase in Q1 EBITDA, with nearly 400 basis points of margin expansion driven by strong cost execution [7][20] - Organic sales were up 3% compared to last year, with seed sales increasing by 2% and crop protection sales by 3% [20][22] - Operating EBITDA margin reached nearly 27%, up 390 basis points, supported by organic sales growth and lower input costs [23] Business Line Data and Key Metrics Changes - The seed business saw organic sales increase by 2%, driven by pricing, while crop protection organic sales rose by 3%, supported by double-digit volume growth for new products and biologicals [11][12] - Seed volume decreased by 1% year-over-year, while crop protection volume increased by 5%, with notable double-digit volume gains from new products [21][22] Market Data and Key Metrics Changes - In the U.S., farmers are projected to shift planted area from soybeans to corn, resulting in a projected 5% increase in corn planting [9] - Enlist beans are expected to be planted on over 65% of U.S. soybean acres in 2025, indicating strong market demand [9] - The crop protection market is anticipated to remain flat with low single-digit volume gains, while Corteva expects high single-digit volume gains to offset low single-digit pricing headwinds [12][28] Company Strategy and Development Direction - Corteva aims to become the leading provider of soybean technology in Brazil, having sold over 3 million units of Conquesta E3 soybeans in the last three years [9] - The company is transitioning to a net out-licenser of technology, with expectations of generating $65 million in benefits this year [19] - The focus on operational excellence and cost improvements is expected to generate net cost savings of $400 million [18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the first quarter performance, noting double-digit EBITDA gains and margin improvements despite potential risks in the second half of the year [18] - The tariff situation is viewed as manageable, with a direct cost impact of approximately $50 million anticipated for 2025 [15][16] - Management highlighted the importance of American farmers and the need for export markets to open up for North American grain and oilseeds [17] Other Important Information - The company plans to introduce approximately 500 new products to the market this year, including around 300 new seed hybrids and varieties [11] - Currency fluctuations posed a significant headwind, impacting sales by approximately 5% [20][24] - Corteva is on track for $1 billion in share repurchases in 2025 [34] Q&A Session Summary Question: Risks in the second half of the year - Management acknowledged the risks but noted that the second half has been derisked since the February guidance, with expectations for crop protection in Brazil to match last year's strong performance [41][42] Question: Price environment in crop protection - Management indicated that while pricing pressures are expected to continue, there are signs of stabilization in the market, particularly with generics from China [66][70] Question: Updates on new growth platforms - Management confirmed that the launch of hybrid red winter wheat is still on track for 2027, with significant revenue potential, and the pilot program for winter canola is expanding [80][81] Question: Tariff impact clarification - Management clarified that the $50 million tariff impact is manageable and not included in the current guidance, as they are working on mitigation strategies [85] Question: Positioning for soybean market shifts - Management noted that U.S. soybean production is essential to meet global demand, despite shifts in imports to Brazil, and emphasized the importance of reopening export markets [92][93]

Financial Data and Key Metrics Changes - Corteva reported a 15% year-over-year increase in Q1 EBITDA, with nearly 400 basis points of margin expansion driven by strong cost execution [6][20] - Organic sales were up 3% compared to last year, with seed sales up 2% and crop protection sales up 3% [20][22] - Operating EBITDA margin reached nearly 27%, reflecting a 390 basis point increase due to organic sales growth and lower input costs [23] Business Line Data and Key Metrics Changes - The seed business saw organic sales increase by 2%, driven by pricing and strong demand, with plans to launch approximately 500 new products this year [10][20] - Crop protection organic sales increased by 3%, supported by double-digit volume growth for new products and biologicals [10][22] - Seed volume was down 1% year-over-year, while crop protection volume was up 5%, with notable gains in nearly every region [21][22] Market Data and Key Metrics Changes - In the U.S., farmers are projected to shift planted area from soybeans to corn, resulting in a projected 5% increase in corn planting [8] - Enlist beans are expected to be planted on over 65% of U.S. soybean acres in 2025, marking it as the number one selling soybean technology in the U.S. [8] - The overall crop protection market is anticipated to remain flat with low single-digit volume gains, while Corteva expects high single-digit volume gains [11][27] Company Strategy and Development Direction - Corteva aims to become the leading provider of soybean technology in Brazil, having sold over 3 million units of Conquesta E3 soybeans in the last three years [8][10] - The company is transitioning to a net out-licenser of technology, expecting to generate $65 million in benefits this year from this strategy [19] - The focus on operational excellence and cost improvements is expected to yield $400 million in net cost savings [17][18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the first quarter performance, noting double-digit EBITDA gains and margin improvements despite potential risks in the second half of the year [17][18] - The tariff situation is viewed as manageable, with a projected direct cost impact of about $50 million for 2025 [14][15] - Management highlighted the importance of American farmers and the need for export markets to open up for North American grain and oilseeds [16] Other Important Information - Currency fluctuations posed a $90 million headwind on EBITDA, primarily due to the Turkish lira and Canadian dollar [24] - The company is on track for $1 billion in share repurchases in 2025 [34] - The first half of the year is expected to show stronger performance than initially anticipated, with net sales projected to be flat compared to the prior year [29] Q&A Session Summary Question: Risks in the second half of the year - Management acknowledged the risks but noted that the second half has been derisked since the February guidance, with expectations for crop protection in Brazil to match last year's strong performance [41][42] Question: Future growth potential in seed portfolio - Management emphasized ongoing excitement about the seed business, particularly in North America and Brazil, with significant opportunities in hybrid wheat and canola [55][60] Question: Pricing environment in crop protection - Management indicated that while pricing pressures are expected to continue, there are signs of stabilization in the market, particularly with generics from China [66][70] Question: Update on new growth platforms - Management confirmed that the launch of hybrid red winter wheat is still on track for 2027, with significant revenue potential [78][79] Question: Clarification on tariff impacts - Management clarified that the $50 million tariff impact is manageable and not included in the current guidance, as they are working on mitigation strategies [84][85]